Wednesday, August 20, 2008

ACE genotype, risk and causal relationship to stroke: Implications for treatment

Opinion statement  The angiotensin-converting enzyme (ACE) catalyzes the formation of angiotensin II and the breakdown of bradykinin into inactive products. The insertion/deletion (I/D) polymorphism affects the activity of the enzyme, wi

No comments: